Identification of a specifically expressed modified form of novel PSP‐94 protein in the secretion of benign prostatic hyperplasia
- 16 April 2003
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 24 (7-8) , 1311-1318
- https://doi.org/10.1002/elps.200390167
Abstract
Using two‐dimensional gel electrophoresis, we investigated the profile of prostatic secretory proteins in human expressed prostatic secretion (EPS) from benign prostate hyperplasia (BPH) patients and compared the patterns with normal controls. We identified three specifically expressed proteins, including prostate secretory protein 61 (PSP61), in EPS from benign BPH patients but absent in normal controls. In addition, we found that PSP61 was a modified isoform of the well‐documented PSP‐94, which had a perfect matching (100% homology) to the first 61 amino acids of the PSP‐94 protein but with a deleted C‐terminus. This shortened PSP61 was not due to alternative splicing of the PSP‐94 gene at transcription level. Our results provide first evidence on the possibility of using PSP61 as a specific biological marker for diagnosis of BPH.Keywords
This publication has 24 references indexed in Scilit:
- Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancerUrology, 2002
- Screening for prostate cancer with prostate-specific antigen: beware the biasesClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agentsUrology, 2001
- PSP94 EXPRESSION AFTER ANDROGEN DEPRIVATION THERAPY: A COMPARATIVE STUDY WITH PROSTATE SPECIFIC ANTIGEN IN BENIGN PROSTATE AND PROSTATE CANCERJournal of Urology, 2000
- Benign prostatic hyperplasia‐associated prostate‐specific antigen (BPSA) shows unique immunoreactivity with anti‐PSA monoclonal antibodiesEuropean Journal of Biochemistry, 2000
- Prostatic secretory protein (PSP94) expression in human female reproductive tissues, breast and in endometrial cancer cell linesJournal of Endocrinology, 2000
- Comparing two‐dimensional electrophoretic gel images across the InternetElectrophoresis, 1997
- Economic issues and the management of benign prostatic hyperplasiaUrology, 1995
- Beta‐microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinomaThe Prostate, 1993
- Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancerThe Prostate, 1987